Page last updated: 2024-08-25

almagate and transforming growth factor beta

almagate has been researched along with transforming growth factor beta in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Raczyńska, D; Raczyńska, K; Zorena, K	1

Reviews

1 review(s) available for almagate and transforming growth factor beta

Article	Year
Biomarkers in diabetic retinopathy and the therapeutic implications. Mediators of inflammation, 2013, Volume: 2013 Topics: Adalimumab; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Aptamers, Nucleotide; Bevacizumab; Biomarkers; Diabetic Retinopathy; Etanercept; Eye Proteins; Humans; Immunoglobulin G; Infliximab; Interleukin-12; Mice; Neovascularization, Pathologic; Nerve Growth Factors; Quality of Life; Ranibizumab; Receptors, Tumor Necrosis Factor; Rituximab; Serpins; Somatomedins; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2013

Article

Year

Biomarkers in diabetic retinopathy and the therapeutic implications.

Mediators of inflammation, 2013, Volume: 2013

Topics: Adalimumab; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Aptamers, Nucleotide; Bevacizumab; Biomarkers; Diabetic Retinopathy; Etanercept; Eye Proteins; Humans; Immunoglobulin G; Infliximab; Interleukin-12; Mice; Neovascularization, Pathologic; Nerve Growth Factors; Quality of Life; Ranibizumab; Receptors, Tumor Necrosis Factor; Rituximab; Serpins; Somatomedins; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2013